Notably, TGIF1 has been found to interact with Smad2-Smad4 complex to further block the activation of the TGFβ signaling pathway, which share close correlation with poor prognosis of EC patients and epithelial-mesenchymal transition in ESCC [17–19]. Here, SMAD2 is linked to esophageal squamous cell carcinoma.